Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit

Citation
G. Angelini et al., Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit, CRIT CARE C, 17(4), 2001, pp. 863
Citations number
64
Categorie Soggetti
Aneshtesia & Intensive Care
Journal title
CRITICAL CARE CLINICS
ISSN journal
07490704 → ACNP
Volume
17
Issue
4
Year of publication
2001
Database
ISI
SICI code
0749-0704(200110)17:4<863:UOPAON>2.0.ZU;2-#
Abstract
Sedative and analgesic medications are the most commonly administered drugs in medical-surgical ICUs in the United States.(22,23,46) A large body of l iterature discusses the side effects and complications associated with the use and misuse of these drugs. A task force from the Society of Critical Ca re Medicine and American Society of Health-Systems Pharmacists currently is revising previously published guidelines that review the use of these agen ts and will propose recommendations for appropriate use of sedatives, analg esics, and neuromuscular-blocking drugs.(28) Sedatives are administered by intermittent injection or by continuous infusions. There are proponents for both methods of administration. Recent data suggest that more careful titr ation to effect sedatives and analgesics and the use of the lowest allowabl e dose with periodic down titration or discontinuation may be associated wi th decreased length of mechanical ventilation, fewer tracheostomies in mech anically ventilated patients, and shortened ICU stay.(33) Sedatives are used to limit stress, to provide comfort, and as pharmacologi c aids to maintain a safe environment for critically ill patients. Various activities, including routine nursing and respiratory care, inva sive proce dures, maintenance of monitoring equipment, and pathophysiologic changes as sociated with the patient's disease or injury, can produce pain and discomf ort. When addressing the needs of the agitated, anxious, or delirious patie nt, pain should always be evaluated and treated when present. A host of factors exacerbate patient agitation. Among these factors are the patient's inability to communicate and distressful environmental factors s uch as excessive auditory, thermal, or visual stimuli. Sleep deprivation is a common cause of agitation (ICU psychosis). In the elderly; this agitatio n often is referred to as sundowner's syndrome. An altered level of conscio usness and lack of comprehension regarding the patient's current state of h ealth frequently lead to anxiety, agitation, and, on occasion, delirium.(23 ) Agitation related to pain and anxiety can have deleterious effects in criti cally ill patients. Agitation can lead to the inadvertent disconnection of life-sustaining therapies, increased oxygen consumption, and myocardial isc hemia. The impact of ICU psychosis with decreased sleep cannot be ignored.( 22) Another less obvious endpoint is the ability to ventilate patients with out the use of neuromuscular-blocking agents; this ventilation reduces the potential for paralysis without adequate sedation or analgesia, decreases t he loss of respiratory drive, and eliminates the development of postparalys is myopathy. Deep sedation may facilitate synchronization of the mechanical ly ventilated patient even when alternative modes of ventilation such as pe rmissive hypercapnia, inverse-ratio ventilation, or prone positioning are u sed.(23,46) Judicious use of sedative drugs in the ICU is important to provide patient comfort without physiologic compromise.(22) An ideal sedative (see box) wou ld produce sedation and amnesia while minimizing cardiovascular lability an d respiratory depression. It would have a rapid onset with a short duration of action. It would be readily titratable and would not accumulate. It wou ld undergo predictable metabolism.(11) It would lack active or toxic metabo lites, and it would be inexpensive.